Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1958 3
1960 1
1962 1
1966 1
1967 1
1969 1
1971 1
1972 1
1974 2
1980 1
1984 1
1985 1
1986 2
1988 1
1989 3
1991 2
1992 4
1993 2
1994 3
1995 8
1996 9
1997 8
1998 11
1999 7
2000 11
2001 15
2002 8
2003 10
2004 7
2005 4
2006 11
2007 7
2008 7
2009 12
2010 11
2011 8
2012 4
2013 6
2014 6
2015 3
2016 5
2017 10
2018 6
2019 3
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

221 results
Results by year
Filters applied: . Clear all
Page 1
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE; SCOT Study Investigators. Sullivan KM, et al. Among authors: nash ra. N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327. N Engl J Med. 2018. PMID: 29298160 Free PMC article. Clinical Trial.
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Muraro PA, Pasquini M, Atkins HL, Bowen JD, Farge D, Fassas A, Freedman MS, Georges GE, Gualandi F, Hamerschlak N, Havrdova E, Kimiskidis VK, Kozak T, Mancardi GL, Massacesi L, Moraes DA, Nash RA, Pavletic S, Ouyang J, Rovira M, Saiz A, Simoes B, Trnený M, Zhu L, Badoglio M, Zhong X, Sormani MP, Saccardi R; Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group. Muraro PA, et al. Among authors: nash ra. JAMA Neurol. 2017 Apr 1;74(4):459-469. doi: 10.1001/jamaneurol.2016.5867. JAMA Neurol. 2017. PMID: 28241268 Free PMC article.
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, Pereira SE, Nash RA, Mielcarek M, Fero ML, Warren EH, Sanders JE, Storb RF, Appelbaum FR, Storer BE, Martin PJ. Flowers ME, et al. Among authors: nash ra. Blood. 2011 Mar 17;117(11):3214-9. doi: 10.1182/blood-2010-08-302109. Epub 2011 Jan 24. Blood. 2011. PMID: 21263156 Free PMC article.
Is scleroderma a vasculopathy?
Fleming JN, Nash RA, Mahoney WM Jr, Schwartz SM. Fleming JN, et al. Among authors: nash ra. Curr Rheumatol Rep. 2009 Apr;11(2):103-10. doi: 10.1007/s11926-009-0015-3. Curr Rheumatol Rep. 2009. PMID: 19296882 Free PMC article. Review.
Metals in medicine.
Nash RA. Nash RA. Altern Ther Health Med. 2005 Jul-Aug;11(4):18-25. Altern Ther Health Med. 2005. PMID: 16053118 Review.
Machine learning predicts stem cell transplant response in severe scleroderma.
Franks JM, Martyanov V, Wang Y, Wood TA, Pinckney A, Crofford LJ, Keyes-Elstein L, Furst DE, Goldmuntz E, Mayes MD, McSweeney P, Nash RA, Sullivan KM, Whitfield ML. Franks JM, et al. Among authors: nash ra. Ann Rheum Dis. 2020 Dec;79(12):1608-1615. doi: 10.1136/annrheumdis-2020-217033. Epub 2020 Sep 15. Ann Rheum Dis. 2020. PMID: 32933919
221 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page